Obesity and demographic ageing are two global megatrends that overlap in a particularly unfavorable way in the cardiovascular system. Both factors independently increase the risk of cardiovascular disease, but also interact at common biological levels: from cellular senescence and mitochondrial dysfunction to structural cardiac and vascular remodeling. The state-of-the-art review by Ruperez et al. in the European Heart Journal sheds light on how obesity accelerates biological cardiovascular ageing, which mechanistic intersections can be found and which metabolic therapy strategies – from calorie restriction to GLP-1 receptor agonists and SGLT2 inhibitors – can modulate these processes.
Autoren
- Tanja Schliebe
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- Pathophysiology, cardiovascular consequences and metabolic interventions
Obesity accelerates cardiovascular ageing
- CKD: counteracting kidney progression and reducing the risk of CVD
Targeted intervention through a multifactorial approach
- COPD therapy
Drug therapy – Update 2025
- Atrial fibrillation: interdisciplinary effort is crucial
Managing risk factors and comorbidities in addition to rhythm control
- Casuistry
Hernia turns out to be a 25 cm long Meckel’s diverticulum
- Side effects under opioid therapy
Is it possible to avoid the inevitable?
- Diagnostics of respiratory viral infections
What is tested when and on whom?
- From symptom to diagnosis